24 articles for A Golebiowski
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Synthesis of quaternarya-amino acid-based arginase inhibitors via the Ugi reaction.
Institutes For Pharmaceutical Discovery
2-Substituted-2-amino-6-boronohexanoic acids as arginase inhibitors.
Institutes For Pharmaceutical Discovery
Discovery of (R)-2-amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic acid and congeners as highly potent inhibitors of human arginases I and II for treatment of myocardial reperfusion injury.
Institutes For Pharmaceutical Discovery
Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.
Procter and Gamble Pharmaceuticals
The synthesis and evaluation of indolylureas as PKCa inhibitors.
Procter & Gamble Pharmaceuticals
Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3).
Procter and Gamble Pharmaceuticals
Novel orally bioavailable piperidine derivatives as extracellular arginase inhibitors developed by a ring expansion.
Molecure
Structure-Based Discovery of High-Affinity Small Molecule Ligands and Development of Tool Probes to Study the Role of Chitinase-3-Like Protein 1.
Molecure
The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).
Procter and Gamble Pharmaceuticals
The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck).
Procter and Gamble Pharmaceuticals
Development of N-4,6-pyrimidine-N-alkyl-N'-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase.
Procter & Gamble Pharmaceuticals
The development of new isoxazolone based inhibitors of tumor necrosis factor-alpha (TNF-alpha) production.
Procter and Gamble Pharmaceuticals
The development of new bicyclic pyrazole-based cytokine synthesis inhibitors.
Procter and Gamble Pharmaceuticals
Benzoxazepine-Derived Selective, Orally Bioavailable Inhibitor of Human Acidic Mammalian Chitinase.
Oncoarendi Therapeutics
Discovery and Pharmacokinetics of Sulfamides and Guanidines as Potent Human Arginase 1 Inhibitors.
Oncoarendi Therapeutics
Development of Dual Chitinase Inhibitors as Potential New Treatment for Respiratory System Diseases.
Oncoarendi Therapeutics
The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-alpha production.
Procter and Gamble Pharmaceuticals
Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-alpha production.
Procter and Gamble Pharmaceuticals
Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma.
Oncoarendi Therapeutics
2-AMINO-5,5-DIMETHYLHEXANOIC ACID DERIVATIVES AS SORTILIN MODULATORS FOR USE IN THE TREATMENT OF DISEASE OF THE CENTRAL NERVOUS SYSTEM
C/O Vesper Bio
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists
Ogeda